Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Neurology firm Link Medicine raises $20mm in Series D round

Executive Summary

In what appears to be its Series D financing, Link Medicine Corp. (addressing Parkinson's, Alzheimer's, and other neurodegenerative diseases at their origin--toxic protein aggregation) has brought in $20mm from nine backers. The company raised $40mm in a Series C round less than two years ago.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies